Evotec SE SEC filings EVOTF
Evotec SE has 190 filings in SEC EDGAR's recent list, going back to Sep 19, 2007. Its latest annual report, Form 20-F, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Filing | Apr 30, 2024 | Dec 31, 2023 |
| NT 20-F | Filing | May 2, 2023 | Dec 31, 2022 |
| SEC STAFF LETTER | Filing | Nov 3, 2021 | — |
| EFFECT | Filing | Nov 3, 2021 | — |
| CERT | Filing | Nov 3, 2021 | — |
| CORRESP | Letter to the SEC | Nov 1, 2021 | — |
| CORRESP | Letter to the SEC | Nov 1, 2021 | — |
| 8-A12B | Filing | Nov 1, 2021 | — |
| CORRESP | Letter to the SEC | Oct 29, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| CORRESP | Letter to the SEC | Oct 28, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2021 | — |
| CORRESP | Letter to the SEC | Oct 22, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 23, 2021 | — |
| DRS/A | Filing | Sep 22, 2021 | — |
| DRSLTR | Filing | Sep 21, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2021 | — |
| DRS/A | Filing | Aug 20, 2021 | — |
| DRSLTR | Filing | Aug 19, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2021 | — |
| DRS | Filing | Jul 9, 2021 | — |
| CT ORDER | Filing | Nov 26, 2012 | — |
| CT ORDER | Filing | Jun 19, 2012 | — |
| CT ORDER | Filing | Nov 17, 2011 | — |
| CT ORDER | Filing | Mar 8, 2011 | — |
| 15F-12B | Filing | Dec 30, 2010 | — |
| CT ORDER | Filing | Jul 1, 2010 | — |
| 25 | Form 25 | Nov 20, 2009 | — |
| CT ORDER | Filing | Jul 29, 2009 | — |
| CERTNAS | Auto-generated paper document | May 5, 2008 | — |
| 8-A12B | Form 8-a | May 1, 2008 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2008 | — |
| 425 | Filing | Mar 28, 2008 | — |
| 425 | Filing | Mar 28, 2008 | — |
| 425 | Form 425 | Mar 26, 2008 | — |
| EFFECT | Filing | Mar 25, 2008 | — |
| EFFECT | Filing | Mar 25, 2008 | — |
| CORRESP | Letter to the SEC | Mar 25, 2008 | — |
| CORRESP | Letter to the SEC | Mar 25, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2008 | — |
| 425 | Rule 425 | Feb 14, 2008 | — |
| 425 | Filing | Jan 9, 2008 | — |
| 425 | Filing | Dec 19, 2007 | — |
| 425 | Filing | Dec 14, 2007 | — |
| 425 | Filing | Dec 14, 2007 | — |
| 425 | Form 425 | Oct 2, 2007 | — |
| 425 | Rule 425 | Sep 19, 2007 | — |
| 425 | Rule 425 | Sep 19, 2007 | — |
| 425 | Rule 425 | Sep 19, 2007 | — |
| 425 | Rule 425 | Sep 19, 2007 | — |
| 425 | Form 425 | Sep 19, 2007 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVO (Nasdaq), EVOTF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Germany
- Headquarters
- Hamburg
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1412558
- Former names
- Evotec AG (until Sep 23, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.